Glycosaminoglycans (GAGs) in OA: What they are, what they do
From university research to the clinical practice, the role of GAGs against osteoarthritis
Hyaluronan: a past, a present. And a future?
The IBSA Symposium, held in Budapest during the 2015 ISIAT Congress, focused on some recent advancements in the field of viscosupplementation.
Individualized management of orthopaedic pain
Management of osteoarthritis: a debate on current worldwide recommendations
IBSA, Laboratoires Genevriér and Rottapharm/Madaus host a round table discussion on "Management of osteaoarthritis: a debate on current worldwide recommendations".
A modern approach to an old disease: Glycosaminoglycans (GAGs) therapy in OA
Nowadays the current treatments available for OA have a moderate effect on pain and joint functions. IBSA Institut Biochimique SA sponsorises a satellite symposium, during the BMJD meeting on the latest therapeutic options.
HA intra-articular treatment: the more accurate the more effective
The best way to handle HA intra-articular treatment, this the issue which will be addressed during the Satellite Symposium sponsored by IBSA.